Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03403114
Other study ID # NI16019
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 1, 2018
Est. completion date October 4, 2019

Study information

Verified date April 2021
Source Assistance Publique - Hôpitaux de Paris
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aims to evaluate the perceptions and knowledge of hospital specialists regarding vaccine recommendations targeting their patients, to study their behavior with respect to these recommendations and to quantify their vaccine hesitancy.


Recruitment information / eligibility

Status Completed
Enrollment 1851
Est. completion date October 4, 2019
Est. primary completion date October 4, 2019
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - To be a physician in one of the participating institutions - Or to be a contract physician in participating institutions Exclusion Criteria: - Interns - Attached practitioners - Emergency physicians

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Questionnaire
a 15min questionnaire

Locations

Country Name City State
France CRC Annecy Annecy
France CIC Besançon Besançon
France CIC Clermont-Ferrand Clermont-Ferrand
France CIC Dijon Dijon
France CIC Lille Lille
France CIC Limoges Limoges
France Service d'Hygiène, Epidémiologie et Prévention, Groupement Hospitalier Edouard Herriot et Unité de recherche clinique ne Immunologie du centre hospitalier Lyon Sud Lyon
France CIC Montpellier Montpellier
France Service de maladies infectieuses Nancy Nancy
France Service de maladies infectieuses Nîmes Nîmes
France CIC Bichat Paris Ile De France
France CIC Cochin Pasteur Paris Ile De France
France CIC Rennes Rennes
France CIC Strasbourg Strasbourg

Sponsors (3)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris Innovative clinical research network in vaccinology (I-REIVAC), Observatoire Régionale de la santé ORS-PACA

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Proportions of Hospital Specialists (HS) with knowledge of vaccine recommendations targeting their patients 15 minutes
Primary Proportions of HS regularly recommending recommended vaccines to their patients 15 minutes
Primary Proportions of HS with doubts about recommended vaccines 15 minutes
Secondary Link between perception of benefits and risks of vaccines, knowledge of vaccine-preventable diseases, trust in different sources of information and vaccine hesitancy will be measured by questionnaire (measure by multiple logistic regressions) 15 minutes
Secondary Measure of attitudes and practices of HS vis-a-vis to vaccination and their specialty by questionnaire number of HS vaccinator or not by specialty in connection with their attitudes and practices 15 minutes
Secondary Percentages of HS feeling sufficiently trained or confident to explain to patients about vaccines 15 minutes
Secondary Percentages of HS claiming to be vaccinated, by type of vaccine 15 minutes
Secondary Percentages of HS children reported vaccinated by type of vaccine 15 minutes